Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 6.28%4.07B | 7.51%2.74B | 12.98%1.34B | 14.92%5.43B | 14.52%3.83B | 14.17%2.55B | 11.49%1.19B | 12.52%4.73B | --3.34B | 17.44%2.23B |
| Operating income | 7.51%2.74B | 14.92%5.43B | 14.17%2.55B | 12.52%4.73B | 17.44%2.23B | |||||
| Cost of sales | ---- | -5.98%-545.45M | ---- | -18.41%-1.09B | ---- | -17.24%-514.67M | ---- | -4.06%-924.64M | ---- | -3.67%-438.98M |
| Operating expenses | -5.98%-545.45M | -18.41%-1.09B | -17.24%-514.67M | -4.06%-924.64M | -3.67%-438.98M | |||||
| Gross profit | 7.90%2.19B | 14.07%4.34B | 13.41%2.03B | 14.78%3.8B | 21.38%1.79B | |||||
| Selling expenses | ---- | -10.10%-1.32B | ---- | -11.47%-2.56B | ---- | -10.71%-1.2B | ---- | -11.12%-2.29B | ---- | -13.80%-1.08B |
| Administrative expenses | ---- | -5.17%-188.74M | ---- | -15.74%-343.21M | ---- | -21.57%-179.46M | ---- | -11.50%-296.55M | ---- | -15.85%-147.63M |
| Special items of operating profit | ---- | 2.16%-79.9M | ---- | -4.96%-158.08M | ---- | -12.65%-81.66M | ---- | 27.12%-150.62M | ---- | 23.36%-72.49M |
| Operating profit | 5.59%607.29M | 20.52%1.28B | 17.03%575.12M | 36.82%1.06B | 61.23%491.42M | |||||
| Financing income | ---- | -67.73%-7.4M | ---- | 33.46%-21.32M | ---- | 77.14%-4.41M | ---- | -30.75%-32.03M | ---- | -124.74%-19.29M |
| Financing cost | ---- | -24.24%-41.98M | ---- | -18.36%-69.62M | ---- | -23.59%-33.79M | ---- | -43.51%-58.83M | ---- | -44.77%-27.34M |
| Special items of earning before tax | ---- | ---- | ---- | -82.30%111K | ---- | -50.88%111K | ---- | 32.56%627K | ---- | 89.92%226K |
| Earning before tax | 3.89%557.92M | 22.36%1.19B | 20.68%537.03M | 36.64%971.46M | 60.39%445.01M | |||||
| Tax | ---- | -12.96%-170.92M | ---- | -15.85%-345.32M | ---- | -9.35%-151.32M | ---- | -23.26%-298.07M | ---- | -57.19%-138.38M |
| After-tax profit from continuing operations | 0.33%386.99M | 25.25%843.4M | 25.79%385.71M | 43.53%673.39M | 61.88%306.63M | |||||
| Earning after tax | 0.33%386.99M | 25.25%843.4M | 25.79%385.71M | 43.53%673.39M | 61.88%306.63M | |||||
| Minority profit | ---- | -49.91%1.11M | ---- | 89.90%4.49M | ---- | 51.44%2.21M | ---- | -40.28%2.37M | ---- | 26.80%1.46M |
| Profit attributable to shareholders | 0.62%385.88M | 25.02%838.91M | 25.67%383.5M | 44.25%671.03M | 62.10%305.17M | |||||
| Basic earnings per share | 0.67%0.151 | 25.19%0.328 | 26.05%0.15 | 43.96%0.262 | 60.81%0.119 | |||||
| Diluted earnings per share | 0.67%0.151 | 25.19%0.328 | 26.05%0.15 | 43.96%0.262 | 60.81%0.119 | |||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | Deloitte & Touche S.p.A. | -- | -- | -- | Deloitte & Touche S.p.A. | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.